2 completed, 1 active not recruiting. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Generalized Tonic Clonic Seizure: new trials by email Literature Review of Generalized Tonic Clonic Seizure trials Research Report on Generalized Tonic Clonic Seizure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RNS System NAUTILUS Study Responsive stimulation, Sham stimulation - Epilepsy, Idiopathic Generalized Epilepsy | Not applicable | Completed | NeuroPace | 100 | 2022-08-09 | 2026-06-08 |
| A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder. Fenfluramine, Placebo - CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure | Phase 3 | Active not recruiting | Zogenix, Inc. | 87 | 2022-03-08 | 2026-04-29 |
| Novel Helmet Design in Patients With Seizures Hövding inflatable helmet - Drug Resistant Epilepsy, Drop Seizures | Not applicable | Completed | Michael A. Gelfand, MD, PhD | 9 | 2017-08-14 | 2025-01-09 |
Epilepsy, Tonic-Clonic (3) · Seizures (2) · CDKL5 deficiency disorder (1) · Drug Resistant Epilepsy (1) · Epilepsy (1) · Epilepsy, Idiopathic Generalized (1) · Spasms, Infantile (1) · Syncope (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Epilepsy, Generalized (3) · Nervous System Diseases (3) · Epilepsy (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Consciousness Disorders (1) · Epileptic Syndromes (1) · Neurobehavioral Manifestations (1) · Unconsciousness (1)
Fenfluramine (1)
Michael A. Gelfand, MD, PhD (1) · NeuroPace (1) · Zogenix, Inc. (1)
United States (3) · Austria (1) · Belgium (1) · Georgia (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Portugal (1) · Spain (1) · United Arab Emirates (1) · United Kingdom (1)
Martha Morrell, MD (1) · Michael Gelfand, MD, PhD (1)
2023 (1)